FINWIRES · TerminalLIVE
FINWIRES

研究快讯:CFRA维持对景顺有限公司股票的买入评级。

By

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:我们将12个月目标价下调2美元至29美元,对IVZ股票的估值分别为:基于我们2027年调整后每股收益3.05美元的9.5倍,基于我们2026年每股收益2.65美元的10.9倍(今日下调0.05美元),而一年期平均远期市盈率为10倍,同业平均市盈率为16倍。景顺(Invesco)公布的2026年第一季度调整后每股收益为0.57美元,低于我们0.62美元的预期,但接近0.58美元的市场普遍预期。同时,该公司连续第11个季度实现正的内生增长,净长期资金流入达218亿美元。受QQQ转换收益和平均资产管理规模(AUM)提升的影响,投资管理费同比增长25.6%至13.8亿美元,但由于QQQ的结构性调整,服务费下降了18.6%。我们认为QQQ转换正按预期推进,显著促进了收入增长,同时也展现了IVZ从其旗舰产品中获取更多费用收入的能力。目前该股的市盈率为9.7倍(基于我们2026年的每股收益预期),股息收益率为3.3%,我们认为该股被低估。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Cincinnati Financial Corp.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target price by $7 to $185, valuing CINF shares (currently yielding 2%) at 20x our 2027 operating EPS estimate of $9.15 (raised by $0.10) and at 21.5x our 2026 EPS estimate of $8.60 (raised by $0.10), versus its five-year average forward multiple of 21x and peer average. CINF posted Q1 operating EPS of $2.10 versus a $0.24 operating loss per share a year ago, matching our estimate and topping the $1.94 consensus view, amid 12% higher operating revenues due to 11% premium growth and 14% higher net investment income, with written premium growth of 7% likely at the upper end of peer averages. We believe CINF's competitive strengths include its facile underwriting style and ability to allocate underwriting capital to areas with the most promising fundamentals, positioning it well despite increasingly competitive market conditions. CINF's ability to consistently produce above-peer growth and underwriting profitability will support the shares' premium valuation versus peers, in our view.

$CINF
Research

Research Alert: CFRA Maintains Hold Opinion On Shares Of Linde Plc

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our 12-month target by $48 to $537, using a P/E of 27.1x, equal to LIN's average forward P/E over the last three years. We raise our 2026 EPS estimate by $0.05 to $18.03 and 2027 by $0.26 to $19.81. LIN reported Q1 adj. EPS of $4.33, beating consensus by $0.06, with 30% operating margins and 24% ROC demonstrating the resilience of its business model. Management raised the low end of full-year guidance to $17.60-$17.90 (7%-9% growth), citing confidence despite geopolitical headwinds. The $7.1B project backlog should reach $8B+ by year-end, driven by Electronics projects supporting AI chip manufacturing. Americas volumes grew 2% Y/Y with double-digit hardgoods growth, though EMEA remains challenged by weak industrial activity. Commercial space is emerging as a significant growth driver, with aerospace sales up double-digits. Helium supply tightness presents upside opportunity beyond guidance. We think shares are fully valued at 25.6x our 2027 EPS estimate, limiting upside potential in the near term.

$LIN
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Silgan Holdings Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target by $13 to $46, based on an EV/EBITDA of 8.9x our 2026 EBITDA estimate, in line with SLGN's three-year average multiple. We increase our 2026 EPS estimate by $0.05 to $3.90 and raise 2027's by $0.05 to $4.20. Metal containers started the year strong, up 2% Y/Y, with pet food product volume up 11%. Management continues to see a long runway for growth in the fragrance, beauty, and health care category now that it is fully integrated into the Weener portfolio. We anticipate further product launches and customer partnerships in 2027, driving growth in this space. Dispensing and specialty closures headwinds are due to higher-cost inventory with volumes adversely affected by severe weather events in North America. Management also noted that volume is likely to improve in 2H 2026 after securing new business wins that have yet to be commercialized but were secured earlier this year.

$SLGN